6568 — KNC Laboratories Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.71 | ||
| Price to Tang. Book | 0.72 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.05 | ||
| EV to EBITDA | 4.28 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.93% | ||
| Return on Equity | 5.97% | ||
| Operating Margin | 11.54% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 7,440.59 | 8,628.01 | 9,154.58 | 8,178.92 | 9,093.71 | n/a | n/a | 8.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +67.18 | +103.34 | -4.38 | -50.64 | +3.44 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
KNC Laboratories Co., Ltd. researches, develops and produces solution business of organic chemicals. The company supplies necessary samples and products for research, development and production activities for product development, manufacture and sale, and also examines the manufacturing method. Organic chemical products are chemical products and intermediates used in the field of medicine and information electronics. Products include display materials, chemicals for semiconductor manufacturing, herbicides, fungicides, drug substances and intermediates, among others.
Directors
- Katsutoshi Hirose CHM (77)
- Hitoshi Miyauchi PRE (63)
- Takuya Mooka DSL
- Koji Matsuo DHR
- Kimihiro Kamasaka EXO
- Masahiro Neya EXO
- Hidemi Yoshida EXO
- Yasuhide Kuriyama OTH
- Yoji Sakito OTH (67)
- Koichi Sasamoto OTH (66)
- Takumi Tanaka OTH (66)
- Mitsukuni Mori IND (70)
- Last Annual
- March 31st, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- January 22nd, 1985
- Public Since
- March 15th, 2018
- No. of Shareholders
- 3,209
- No. of Employees
- 340
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 7,741,320
- Address
- 7-1-19, Minatojimaminami-machi, Chuo-ku, KOBE-SHI, 650-0047
- Web
- https://www.kncweb.co.jp/
- Phone
- +81 789559900
- Auditors
- Sakurabashi & Co.
Latest News for 6568
Upcoming Events for 6568
Q2 2027 KNC Laboratories Co Ltd Earnings Release
Dividend For 6568.T - 17.0000 JPY
Similar to 6568
Achilles
Tokyo Stock Exchange
ADEKA
Tokyo Stock Exchange
Aica Kogyo
Tokyo Stock Exchange
AIR WATER
Tokyo Stock Exchange
Arakawa Chemical Industries
Tokyo Stock Exchange
FAQ
As of Today at 03:38 UTC, shares in KNC Laboratories are trading at ¥1,294. This share price information is delayed by 15 minutes.
Shares in KNC Laboratories last closed at ¥1,294 and the price had moved by +12.13% over the past 365 days. In terms of relative price strength the KNC Laboratories share price has underperformed the Nikkei 225 Index by -17.13% over the past year.
The overall consensus recommendation for KNC Laboratories is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe KNC Laboratories dividend yield is 2.55% based on the trailing twelve month period.
Last year, KNC Laboratories paid a total dividend of ¥33, and it currently has a trailing dividend yield of 2.55%.Looking ahead, the next dividend pay date is 2026-12-07.
We do not have data on when KNC Laboratories is to next pay dividends. The historic dividend yield on KNC Laboratories shares is currently 2.55%.
To buy shares in KNC Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥1,294, shares in KNC Laboratories had a market capitalisation of ¥10bn.
Here are the trading details for KNC Laboratories:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 6568
Based on an overall assessment of its quality, value and momentum KNC Laboratories is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in KNC Laboratories is ¥1,800. That is 39.1% above the last closing price of ¥1,294.
Analysts covering KNC Laboratories currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like KNC Laboratories. Over the past six months, its share price has underperformed the Nikkei 225 Index by -4.49%.
As of the last closing price of ¥1,294, shares in KNC Laboratories were trading +3.78% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The KNC Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥1,294.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
KNC Laboratories' management team is headed by:
- Katsutoshi Hirose - CHM
- Hitoshi Miyauchi - PRE
- Takuya Mooka - DSL
- Koji Matsuo - DHR
- Kimihiro Kamasaka - EXO
- Masahiro Neya - EXO
- Hidemi Yoshida - EXO
- Yasuhide Kuriyama - OTH
- Yoji Sakito - OTH
- Koichi Sasamoto - OTH
- Takumi Tanaka - OTH
- Mitsukuni Mori - IND